Currently available GLP-1 receptor agonists in the United States include exenatide (Byetta, Bydureon BCise), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), semaglutide (Ozempic, Wegovy, Rybelsus), and tirzepatide (Mounjaro, Zepbound), though tirzepatide is technically a dual GIP/GLP-1 receptor agonist
Why Choose Acorn Pharmas
GLP-1s dont just nudge your body toward weight loss
Subcutaneous injection technique Subcutaneous administration involves injecting into the fatty layer beneath the skin
Poeran et al.s study showed that through multivariable models, preoperative use of GLP-1 RA use was not significantly associated with increased odds of aspiration (OR 1.08
To adapt comfortably, start with a smaller serving and slowly increase it